Anti-inflammatory properties of cryptolepine.
Olajide, O.A. Ajayi, A.A. Wright, Colin W.
Olajide, O.A.
Ajayi, A.A.
Wright, Colin W.
Publication Date
2010-12-07
End of Embargo
Supervisor
Rights
Peer-Reviewed
Yes
Open Access status
closedAccess
Accepted for publication
Institution
Department
Awarded
Embargo end date
Collections
Additional title
Abstract
Cryptolepine is the major alkaloid of the West African shrub, Cryptolepis sanguinolenta. Cryptolepine has
been shown to inhibit nitric oxide production, and DNA binding of Nuclear Factor-kappa B following
inflammatory stimuli in vitro. In order to validate the anti-inflammatory property of this compound in vivo,
we investigated its effects on a number of animal models of inflammation. Cryptolepine (10¿40 mg/kg i.p.)
produced significant dose-dependent inhibition of the carrageenan-induced rat paw oedema, and carrageenaninduced
pleurisy in rats. These effects were compared with those of the non-steroidal anti-inflammatory drug
indomethacin (10 mg/kg). At doses of 10¿40 mg/kg i.p., cryptolepine inhibited lipopolysaccharide (LPS)-induced
microvascular permeability in mice in a dose-related fashion. Oral administration of up to 40 mg/kg of the
compound for four consecutive days did not induce gastric lesion formation in rats. Analgesic activity was also
exhibited by cryptolepine through a dose-related (10¿40 mg/kg i.p.) inhibition of writhing induced by i.p.
administration of acetic acid in mice. The results of this study reveal that cryptolepine possesses in vivo
anti-inflammatory activity.Copyright © 2009 John Wiley & Sons, Ltd.
Version
No full-text in the repository
Citation
Olajide, O. A., Ajayi, A. A. and Wright, C. W. (2009). Anti-inflammatory properties of cryptolepine. Phytotherapy Research. Vol. 23, No. 10, pp. 1421¿1425.
Link to publisher’s version
Link to published version
Link to Version of Record
Type
Article